[Skip to content]

Print this page

Local network oncology regimens

Documents within this category

application/pdfOlaparib or Placebo (PIN study) (199KB)Download
 A randomised phase II trial of Olaparib maintenance versus placebo monotherapy in patients with chemosensitive advanced non-small cell lung cancer.
application/pdfOlaparib or Placebo (PIN Study) (166KB)Download
application/pdfOral Vinorelbine (VIM Trial) (153KB)Download
application/pdfOsimertinib (91KB)Download
application/pdfPaclitaxel + Carboplatin (125KB)Download
 Paclitaxel + Carboplatin Regimen
application/pdfPembrolizumab (153KB)Download
 Second line NSCLC
application/pdfPembrolizumab (EAMS) (125KB)Download
 Metastatic (stage IV) non-small cell lung cancer (NSCLC) with PD-L1 tumour proportion score ≥50% as determined by a validated test; no prior systemic chemotherapy received for stage IV disease; EGFR...
application/pdfPembrolizumab (Fixed dose) (119KB)Download
 1st line NSCLC - fixed dose
application/pdfPemetrexed + Carboplatin (181KB)Download
 Pemetrexed + Carboplatin Regimen
application/pdfPemetrexed + Cisplatin (190KB)Download
 Pemetrexed+Cisplatin Regimen
Page: [1] [2] [3] [4]